Essential role of endothelial Smad4 in vascular remodeling and integrity

Molecular and Cellular Biology

Volumn 27, Issue 21, 2007, Pages 7683-7692

  Lan, Yu ^a   Liu, Bing ^b   Yao, Huiyu ^b   Li, Fangfei ^a   Weng, Tujun ^a   Yang, Guan ^a   Li, Wenlong ^a   Cheng, Xuan ^a   Mao, Ning ^b   Yang, Xiao ^a  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; CONNEXIN 43; CRE RECOMBINASE; SMAD4 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOMEGALY; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; EMBRYO; ENDOCARDIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GAP JUNCTION; GENE; GENE DELETION; IN VITRO STUDY; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMAD4 GENE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANGIOPOIETIN-2; ANIMALS; BLOOD VESSELS; CONNEXIN 43; EMBRYO LOSS; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTEGRASES; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SPECIFICITY; PERICYTES; PLACENTA; PREGNANCY; RECEPTOR, TIE-2; SMAD4 PROTEIN;

MUS;

EID: 35648947847     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00577-07     Document Type: Article

References (50)

1. Anghelina, M., L. Moldovan, and N. I. Moldovan. 2005. Preferential activity of Tie2 promoter in arteriolar endothelium. J. Cell Mol. Med. 9:113-121.
2. Antonelli-Orlidge, A., K. B. Saunders, S. R. Smith, and P. A. D'Amore. 1989. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86:4544-4548.
3. Armstrong, E. J., and J. Bischoff. 2004. Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95:459-470.
4. Armulik, A., A. Abramsson, and C. Betsholtz. 2005. Endothelial/pericyte interactions. Circ. Res. 97:512-523.
5. Carvalho, R. L., L. Jonker, M. J. Goumans, J. Larsson, P. Bouwman, S. Karlsson, P. T. Dijke, H. M. Arthur, and C. L. Mummery. 2004. Defective paracrine signaling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131:6237-6247.
6. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
7. Dickson, M. C., J. S. Martin, F. M. Cousins, A. B. Kulkarni, S. Karlsson, and R. J. Akhurst. 1995. Defective hematopoiesis and vasculogenesis in transforming growth factor-β1 knockout mice. Development 121:1845-1854.
8. Eklund, L., and B. R. Olsen. 2006. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp. Cell Res. 312:630-641.
9. Ema, M., S. Takahashi, and J. Rossant. 2006. Deletion of the selection cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1 expression in multipotent mesodermal progenitors. Blood 107:111-117.
10. Gale, N. W., G. Thurston, S. F. Hackett, R. Renard, Q. Wang, J. McClain, C. Martin, C. Witte, M. H. Witte, D. Jackson, C. Suri, P. A. Campochiaro, S. J. Wiegand, and G. D. Yancopoulos. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3:411-423.
11. Gallione, C. J., G. M. Repetto, E. Legius, A. K. Rustgi, S. L. Schelley, S. Tejpar, G. Mitchell, E. Drouin, C. J. Westermann, and D. A. Marchuk. 2004. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363:852-859.
12. Goumans, M. J., G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke. 2002. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J. 21:1743-1753.
13. Hata, A., J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou, and J. Massague. 2000. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100:229-240.
14. Hatzopoulos, A. K., J. Folkman, E. Vasile, G. K. Eiselen, and R. D. Rosenberg. 1998. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125:1457-1468.
15. Hirschi, K. K., J. M. Burt, K. D. Hirschi, and C. Dai. 2003. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ. Res. 93:429-437.
16. Hirschi, K. K., S. A. Rohovsky, and P. A. D'Amore. 1998. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141:805-814.
17. Hocevar, B. A., T. L. Brown, and P. H. Howe. 1999. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18:1345-1356.
18. Johnson, D. W., J. N. Berg, M. A. Baldwin, C. J. Gallione, I. Marondel, S. J. Yoon, T. T. Stenzel, M. Speer, M. A. Pericak-Vance, A. Diamond, A. E. Guttmacher, C. E. Jackson, L. Attisano, R. Kucherlapati, M. E. Porteous, and D. A. Marchuk. 1996. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13:189-195.
19. Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, and M. Yanagisawa. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230-242.
20. Kwak, B. R., M. S. Pepper, D. B. Gros, and P. Meda. 2001. Inhibition of endothelial wound repair by dominant negative connexin inhibitors. Mol. Biol. Cell 12:831-845.
21. Larson, D. M., T. G. Christensen, G. D. Sagar, and E. C. Beyer. 2001. TGF-beta1 induces an accumulation of connexin43 in a lysosomal compartment in endothelial cells. Endothelium 8:255-260.
22. Larsson, J., M. J. Goumans, L. J. Sjostrand, M. A. van Rooijen, D. Ward, P. Leveen, X. Xu, P. ten Dijke, C. L. Mummery, and S. Karlsson. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 20:1663-1673.
23. Lebrin, F., M. Deckers, P. Bertolino, and P. Ten Dijke. 2005. TGF-beta receptor function in the endothelium. Cardiovasc. Res. 65:599-608.
24. Li, D. Y., L. K. Sorensen, B. S. Brooke, L. D. Urness, E. C. Davis, D. G. Taylor, B. B. Boak, and D. P. Wendel. 1999. Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537.
25. Li, W. E., K. Waldo, K. L. Linask, T. Chen, A. Wessels, M. S. Parmacek, M. L. Kirby, and C. W. Lo. 2002. An essential role for connexin43 gap junctions in mouse coronary artery development. Development 129:2031-2042.
26. Li, W. L., X. Cheng, X. H. Tan, J. S. Zhang, Y. S. Sun, L. Chen, and X. Yang. 2005. Endothelial cell-specific expression of Cre recombinase in transgenic mice. Yi Chuan Xue Bao 32:909-915.
27. Maisonpierre, P. C., C. Suri, P. F. Jones, S. Bartunkova, S. J. Wiegand, C. Radziejewski, D. Compton, J. McClain, T. H. Aldrich, N. Papadopoulos, T. J. Daly, S. Davis, T. N. Sato, and G. D. Yancopoulos. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
28. Mandriota, S. J., and M. S. Pepper. 1998. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83:852-859.
29. McAllister, K. A., K. M. Grogg, D. W. Johnson, C. J. Gallione, M. A. Baldwin, C. E. Jackson, E. A. Helmbold, D. S. Markel, W. C. McKinnon, J. Murrell, et al. 1994. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8:345-351.
30. + progenitor: contribution to muscle lineage. Genesis 35:153-159.
31. Oh, S. P., T. Seki, K. A. Goss, T. Imamura, Y. Yi, P. K. Donahoe, L. Li, K. Miyazono, P. ten Dijke, S. Kim, and E. Li. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97:2626-2631.
32. Oshima, M., H. Oshima, and M. M. Taketo. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:297-302.
33. Ota, T., M. Fujii, T. Sugizaki, M. Ishii, K. Miyazawa, H. Aburatani, and K. Miyazono. 2002. Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J. Cell Physiol. 193:299-318.
34. Park, C., K. Lavine, Y. Mishina, C. X. Deng, D. M. Ornitz, and K. Choi. 2006. Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 133:3473-3484.
35. Scharpfenecker, M., U. Fiedler, Y. Reiss, and H. G. Augustin. 2005. The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 118:771-780.
36. Schlaeger, T. M., S. Bartunkova, J. A. Lawitts, G. Teichmann, W. Risau, U. Deutsch, and T. N. Sato. 1997. Uniform vascular-endothelial-cell- specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA 94:3058-3063.
37. Schwarte-Waldhoff, I., O. V. Volpert, N. P. Bouck, B. Sipos, S. A. Hahn, S. Klein-Scory, J. Luttges, G. Kloppel, U. Graeven, C. Eilert-Micus, A. Hintelmann, and W. Schmiegel. 2000. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl. Acad. Sci. USA 97:9624-9629.
38. Seki, T., J. Yun, and S. P. Oh. 2003. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ. Res. 93:682-689.
39. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
40. Sun, Y., J. Zhou, X. Liao, Y. Lu, C. Deng, P. Huang, Q. Chen, and X. Yang. 2005. Disruption of Smad5 gene induces mitochondria-dependent apoptosis in cardiomyocytes. Exp. Cell Res. 306:85-93.
41. Tang, N., F. Mack, V. H. Haase, M. C. Simon, and R. S. Johnson. 2006. pVHL function is essential for endothelial extracellular matrix deposition. Mol. Cell. Biol. 26:2519-2530.
42. Taylor, L. M., and L. M. Khachigian. 2000. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J. Biol. Chem. 275:16709-16716.
43. ten Dijke, P., and C. S. Hill. 2004. New insights into TGF-β-Smad signaling. Trends Biochem. Sci. 29:265-273.
44. Tsuchida, K., Y. Zhu, S. Siva, S. R. Dunn, and K. Sharma. 2003. Role of Smad4 on TGF-β-induced extracellular matrix stimulation in mesangial cells. Kidney Int. 63:2000-2009.
45. Usui, T., M. Takase, Y. Kaji, K. Suzuki, K. Ishida, T. Tsuru, K. Miyata, M. Kawabata, and H. Yamashita. 1998. Extracellular matrix production regulation by TGF-β in corneal endothelial cells. Investig. Ophthalmol. Vis. Sci. 39:1981-1989.
46. Valdimarsdottir, G., M. J. Goumans, A. Rosendahl, M. Brugman, S. Itoh, F. Lebrin, P. Sideras, and P. ten Dijke. 2002. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells. Circulation 106:2263-2270.
47. Wu, X., J. Ma, J. D. Han, N. Wang, and Y. G. Chen. 2006. Distinct regulation of gene expression in human endothelial cells by TGF-β and its receptors. Microvasc. Res. 71:12-19.
48. Yang, X., L. H. Castilla, X. Xu, C. Li, J. Gotay, M. Weinstein, P. P. Liu, and C. X. Deng. 1999. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-1580.
49. Yang, X., C. Li, P. L. Herrera, and C. X. Deng. 2002. Generation of Smad4/Dpc4 conditional knockout mice. Genesis 32:80-81.
50. Yang, X., C. Li, X. Xu, and C. Deng. 1998. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95:3667-3672.